Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: Report of the Committee for the Respiratory System, Japan Society of Chemotherapy

Journal of Infection and Chemotherapy

Volumn 5, Issue 2, 1999, Pages 110-123

  Saito, Atsushi ^a   Miki, Fumio ^b   Oizumi, Kotaro ^c   Rikitomi, Naoto ^d   Watanabe, Akira ^e   Koga, Hironobu ^d   Niki, Yoshito ^f   Kusano, Nobuchika ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Department of Plastic Surgery Tane General Hospital   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f Nagasaki University   (Japan)

Author keywords

Antimicrobial agents; Clinical evaluation method; Committee report; Respiratory infection

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; NEW DRUG;

ARTICLE; CLINICAL RESEARCH; DATA ANALYSIS; DISEASE CARRIER; DRUG EFFICACY; DRUG RESEARCH; HUMAN; PATIENT SELECTION; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; STANDARDIZATION; TREATMENT OUTCOME;

EID: 0032982548     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050020     Document Type: Article

References (48)

1. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and Food and Drug Administration. Clin Infect Dis 1992; 15(Suppl 1):S62-S88.
2. Beam TR, Gilbert DN, Kunin CM. European guidelines for the evaluation of anti-infective drug products 1993. Munich: European Society of Microbiology and Infectious Diseases (ESCMID), 1993.
3. Naito S. General guidelines for clinical evaluation for newly developed medical drugs. In: Jpn Assoc Official Pub, editors. Guidelines for clinical evaluation for new medical drugs Tokyo: YakuziNippo, 1992;12-28.
4. Naito S. Guidelines for statistical analysis for clinical trials. In: Jpn Assoc Official Pub, editors. Guidelines for clinical evaluation for new medical drugs Tokyo: Yakuzi-Nippo, 1992;36-59.
5. Norrby SR. Clinical evaluation of new antimicrobial drugs. Jpn J Chemother 1996;44:27-31.
6. Lumpkin MM. View and current status of the US guidelines: from the view of the FDA. Jpn J Chemother 1996;44:32-5.
7. Darrow WR. View and current status of the US Guidelines: from the view of sponsors. Jpn J Chemother 1996;44:35-7.
8. Saito A. Clinical evaluation of antimicrobial agents: from the Committee for the Respiratory System. Jpn J Chemother 1996;44:680-706.
9. Kawada K. Clinical evaluation of antimicrobial agents: from the Committee for the Urinary System. Jpn J Chemother 1996;44:39-40.
10. Tanimura H. Clinical evaluation of antimicrobial agents: from the Committee for Preventing the Postoperative Infections. Jpn J Chemother 1996;44:41-2.
11. Beam TR, Gilbert DN, Kunin CM. General guidelines for the clinical evaluation of anti-infective drug products. Clin Infect Dis 1992;15(Suppl 1):S5-S32.
12. Sunakawa K, Yamaguchi K, Shiba T, Onodera S, Hanaya Y, Chiba H. Guideline for the clinical evaluation for anti-infective agents. Jpn J Antibiot 1997;50:107-42.
13. Pharmaceutical and Medical Safety Bureau, Ministry of Health and Welfare, Japan. Guideline for the clinical evaluation for antiinfective agents. Jpn J Chemother 1998;46:410-37.
14. Sunakawa K. International guidelines for the clinical evaluation of anti-infective drugs. Jpn J Antibiot 1997;50:87-106.
15. Saito A, Miki F, Oizumi K, Rikitomi N, Watanabe A, Koga H, et al. Report from the Committee for the Respiratory System: General guidelines for the clinical evaluation of anti-infective drugs. Jpn J Antibiot 1996;44:680-706.
16. Committee for Side Effects on the Trials of Anti-Infective Drugs. Standardization of side effects and abnormalities of laboratory findings. Jpn J Antibiot 1996;39:678-89.
17. Mossad SB. Treatment of the common cold. BMJ 1998; 4:317(7150):33-6.
18. Smith A. Effects of the common cold on mood and performance. Psychoneuroendocrinology 1998;23:733-9.
19. Lilja M. Initial events in the pathogenesis of acute tonsillitis caused by Streptococcus pyogenes. Int J Pediatr Otorhinolaryngol 1998; 45:15-20.
20. Gaffney RJ. Bacteriology of normal and diseased tonsils assessed by fine-needle aspiration: Haemophilia influenzae and the pathogenesis of recurrent acute tonsillitis. Clin Otolaryngol 1998; 23:181-5.
21. Agren K. Haemophilus influenzae and Streptococcus pyogenes group A challenge induce a Th1 type of cytokine response in cells obtained from tonsillar hypertrophy and recurrent tonsillitis. ORL J Otorhinolaryngol Relat Spec 1998;60:35-41.
22. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics 1996;97:949-54.
23. Constantiniu S. Study of the streptococcal acute pharyngitis and carrier state. Adv Exp Med Biol 1997;418:53-5.
24. Seehusen DA. Use of antibiotics in patients with acute bronchitis. Am Fam Physician 1998;58:1303.
25. Cimolai N. Mycoplasma pneumoniae respiratory infection. Pediatr Rev 1998;19:327-31.
26. File TM Jr. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella. Infect Dis Clin North Am 1998;12:569-92.
27. Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 1997;6:396-9.
28. Ogihara H. Evaluation of sputum Gram smears for the rapid etiological diagnosis of the bacterial respiratory infection. Rinsho Kensa 1991;35:1351-5.
29. Tay ST. A review of the serological results obtained in a routine diagnostic laboratory for Mycoplasma pneumoniae infections. Malays J Pathol 1995;17:35-7.
30. Petitjean J. Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults. J Med Microbiol 1998;47:615-21.
31. Oeffinger KC. Diagnosis of acute bronchitis in adults: a national survey of family physicians. J Fam Pract 1997;45:402-9.
32. Bartlett JG, Breiman RF, Mandell LA, File TM. Guidelines from the Infectious Diseases Society of America. Community-acquired pneumonia in adults: guideline for management. Clin Infect Dis 1998;26:811-38.
33. Woodhead M. Community-acquired pneumonia guidelines - an international comparison: a view from Europe. Chest 1998;113(3 Suppl)e:s183-s187.
34. File TM, Tan JS. Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia. Curr Opin Pulm Med 1997;3:89-97.
35. Niederman MS, Bass JB Jr, Campbell GD, Fein AL, Grossman RF, Mandel LA, et al. American Thoracic Society-guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
36. Reynolds H. Respiratory infections: community-acquired pneumonia and new microbes. Lung 1996;174:207-24.
37. Lieberman D, Schlaeffer F, Boldur I, Horowitz S, Friedman MG, Leinonen M, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a 1-year prospective study of 346 consecutive patients. Thorax 1996;51:179-84.
38. Marrie TJ, Peeling RW, Fine MJ, Siger DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996;101:508-15.
39. Pereira JC, Escuder MM. The importance of clinical symptoms and signs in the diagnosis of community-acquired pneumonia. J Trop Pediatr 1998;44:18-24.
40. Sopena N, Sabria-Leal M, Pedro-Botet ML, Padilla E, Dominguez J, Morera J, Tudela P. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998;113:1195-200.
41. Gencay M. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir,Turkey.Eur J Epidemiol 1998;14:505-9.
42. Andersen P. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasme, Legionella and viruses. Thorax 1998; 53:302-7.
43. Verkooyen RP. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 1998;36:2301-7.
44. Woodhead M. Management of lower respiratory tract infections in out-patients. Monaldi Arch Chest Dis 1997;52:486-91.
45. Ball P. Infective pathogenesis and outcomes in chronic bronchitis. Curr Opin Pulm Med 1996;2:181-5.
46. Eller J. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113:1542-8.
47. Reimer LG. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis 1998;26:742-8.
48. Tanimura H. Guidelines for clinical evaluation of antibiotic prophylaxis after surgical treatment.Jpn J Chemother 1997;45:553-651.